StockMarketWire.com - Collagen Solutions has announced a research collaboration with Blond McIndoe Research Foundation, a not for profit centre for regenerative medicine based at the Queen Victoria Hospital, East Grinstead, a world leading centre for the treatment of burns.

The pilot study will investigate the use of primary human skin cells used in formulation with Collagen Solutions products with a view to developing more effective treatments for burns, thereby reducing the burden and limitation of skin grafting.

It is hoped that the combination of BMRF's experience in culturing cells specifically for treatment of burns and the use of high quality medical grade collagen will also enable the use of more effective application technologies for these types of injuries.


At 9:01am: [LON:COS] COLLAGEN SOLUTIONS ORD 1P share price was 0p at 6.25p



Story provided by StockMarketWire.com